Literature DB >> 35325254

Coronavirus disease 2019-lessons learnt.

Seamas C Donnelly1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35325254      PMCID: PMC9383545          DOI: 10.1093/qjmed/hcac049

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


× No keyword cloud information.

Well-controlled diabetes not a contraindication for intensive care unit care in acute coronavirus disease 2019 infection

Those of us responsible for the in-patient care of coronavirus disease 2019 (COVID-19) patients over the last 2 years know that difficult decisions were made in relation to which patients were for escalation of treatment beyond ward-based care. Early on in the pandemic, it was recognized that certain pre-existing disease states were associated with a significant adverse prognosis and consequently influenced our decisions. These co-morbidities included chronic heart failure, chronic renal failure, hypertension, chronic lung conditions and diabetes. As hospital resources, and in particular intensive care unit resources, were stretched during each of the COVID-19 surges—oftentimes a single co-morbidity significantly influenced the decision to escalate or not. The QJM has over recent months published seminal articles in relation to prognosis and outcome for COVID-19 infection. We are now heading into the third year of the pandemic and it is important that we highlight lessons learnt over that time to better inform future infectious epidemic/pandemics. We therefore wish to highlight the important study by Dr Zhan and colleagues from Southwest Medical University, and the Army Medical University, China in which they prospectively evaluated the association between glycaemic control on hospital presentation and outcome in 574 COVID-19 patients with type-2 diabetes in Wuhan, China followed for up to 12 months. Reported mortality in pre-OMICRON COVID-19 infection for the general population with no underlying health conditions is 3%. In this study, researchers reported a significant 75% reduction in mortality in the well-controlled diabetic group compared to the poorly controlled diabetes cohort with a mortality of 2.5%. In the context of lessons learnt—we need to refine our criteria for diabetic patients admitted to hospital with COVID-19 infection in the context of the decision to escalate beyond ward-based care—a history of well-controlled disease has the same prognosis as the healthy population.

Invitation to submit photographs for the QJM cover

A call to all you budding photographers—we extend an invitation to you to submit photographs for consideration for the cover of the QJM. Photographs can be in black and white or colour and of high definition (>300 dpi, File size <5 MB). In general, we avoid photographs where individuals are in the photo who can be identified. Please provide a brief caption and include a credit for the photographer or artist. Please email your images to qjmedj.oup@kwglobal.com.
  7 in total

1.  Low vitamin D levels and prognosis in a COVID-19 paediatric population: a systematic review.

Authors:  Komal Shah; Varna V P; Apurvakumar Pandya; Deepak Saxena
Journal:  QJM       Date:  2021-07-22

2.  COVID-19 and chronic renal disease: clinical characteristics and prognosis.

Authors:  D Yang; Y Xiao; J Chen; Y Chen; P Luo; Q Liu; C Yang; M Xiong; Y Zhang; X Liu; H Chen; A Deng; K Huang; B Cheng; A Peng
Journal:  QJM       Date:  2020-11-01

3.  The risk of thrombosis after acute-COVID-19 infection.

Authors:  Marco Zuin; Gianluca Rigatelli; Giovanni Zuliani; Loris Roncon
Journal:  QJM       Date:  2021-03-15

4.  Dyslipidaemia and mortality in COVID-19 patients - a meta-analysis.

Authors:  Marco Zuin; Gianluca Rigatelli; Claudio Bilato; Carlo Cervellati; Giovanni Zuliani; Loris Roncon
Journal:  QJM       Date:  2021-04-02

5.  Defining heart disease risk for death in COVID-19 infection.

Authors:  J Li; T Guo; D Dong; X Zhang; X Chen; Y Feng; B Wei; W Zhang; M Zhao; J Wan
Journal:  QJM       Date:  2020-12-01

6.  Association of Padua prediction score with in-hospital prognosis in COVID-19 patients.

Authors:  D X Zeng; J L Xu; Q X Mao; R Liu; W Y Zhang; H Y Qian; L Xu
Journal:  QJM       Date:  2020-11-01

7.  Mortality Rate of Patients With COVID-19 Based on Underlying Health Conditions.

Authors:  Won-Young Choi
Journal:  Disaster Med Public Health Prep       Date:  2021-05-03       Impact factor: 1.385

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.